Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Second Edition BOGP (0)
Advocacy (policy advocacy, lobbying)
Musculoskeletal/Multiple Sclerosis (MS) (1)
Regulatory Body (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Transparency in communication and documentation
Health Technology Assessment (HTA) activities